Drug Delivery Technology Market Grow at 7.2% CAGR and to Reach US$ 1,669 Billion by 2021
Report defines, describes, & forecast drug delivery technology market on basis of route of administration, facility of use, and region. It provides detailed information regarding major factors influencing growth of the market (drivers, restraints, opportu
(EMAILWIRE.COM, October 02, 2018 ) Drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during forecast period. Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, & new product launches are some of major factors driving growth of market. Access the Free Trial Papers of Drgu Delivery Technology Market as Follows at http://www.reportsnreports.com/contacts/requestsample.aspx?name=237071 .
The drug delivery technology market segmented based on route of administration, facility of use, and region. Based on route of administration, market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market.
Drug delivery technology market report covers:
• Current and forecast assessment of the drug delivery technology market.
• Country-wise assessment of each of the segments
• Global market share analysis for major segments of the drug delivery technology market
• Adoption trends of various drug delivery technologies for major geographic markets
• Five-year coverage of strategic developments of top players in the drug delivery technology market
• Product Portfolio mapping of leading players in the drug delivery technology market
Drug delivery technology market segmented into hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. Hospitals segment expected to account for largest share of market. This can be primarily attributed to advantages like significant number of inpatient and outpatient visits in hospitals as compared to other end users and requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.
Complete Report with Discount on Drug Delivery Technology Market spread across 252 Pages, Profiling 12 Companies and Supported with 170 Tables and 37 Figures is now available at http://www.reportsnreports.com/contacts/discount.aspx?name=237071 .
Prominent players in drug delivery technology market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).
Premium Insights
1 Topical Drug Delivery: Market Overview
2 Drug Delivery Technology Market, By Facility of Use
3 Solid Oral Drug Delivery Technology Market, By Dosage Form
4 Drug Delivery Technology Market, By Route of Administration
5 Geographical Snapshot of the Drug Delivery Technology Market
Asia is expected to be fastest-growing region in the drug delivery technology market from 2016 to 2021.Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.
More Details on “Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021” report @ https://www.reportsnreports.com/reports/237071-drug-delivery-technologies-market-metered-dose-inhalers-needle-free-injectors-auto-injectors-nasal-sprays-transdermal-patches-nebulizers-infusion-pumps-drug-eluting-stents-sustained-release-ocular-implants-global-forecasts-to-2017.html .
The hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to factors such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Competitive Situations & Trends
4 Product Launches & Approvals
5 Partnerships, Agreements, and Collaborations
6 Acquisitions, Mergers, and Joint Ventures
7 Expansions
Additionally, the increasing need for drug administration due to the rising prevalence of chronic diseases, patient compliance, and safety are all factors contributing to the growth of the market for hospitals.
The drug delivery technology market segmented based on route of administration, facility of use, and region. Based on route of administration, market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market.
Drug delivery technology market report covers:
• Current and forecast assessment of the drug delivery technology market.
• Country-wise assessment of each of the segments
• Global market share analysis for major segments of the drug delivery technology market
• Adoption trends of various drug delivery technologies for major geographic markets
• Five-year coverage of strategic developments of top players in the drug delivery technology market
• Product Portfolio mapping of leading players in the drug delivery technology market
Drug delivery technology market segmented into hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. Hospitals segment expected to account for largest share of market. This can be primarily attributed to advantages like significant number of inpatient and outpatient visits in hospitals as compared to other end users and requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.
Complete Report with Discount on Drug Delivery Technology Market spread across 252 Pages, Profiling 12 Companies and Supported with 170 Tables and 37 Figures is now available at http://www.reportsnreports.com/contacts/discount.aspx?name=237071 .
Prominent players in drug delivery technology market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).
Premium Insights
1 Topical Drug Delivery: Market Overview
2 Drug Delivery Technology Market, By Facility of Use
3 Solid Oral Drug Delivery Technology Market, By Dosage Form
4 Drug Delivery Technology Market, By Route of Administration
5 Geographical Snapshot of the Drug Delivery Technology Market
Asia is expected to be fastest-growing region in the drug delivery technology market from 2016 to 2021.Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.
More Details on “Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021” report @ https://www.reportsnreports.com/reports/237071-drug-delivery-technologies-market-metered-dose-inhalers-needle-free-injectors-auto-injectors-nasal-sprays-transdermal-patches-nebulizers-infusion-pumps-drug-eluting-stents-sustained-release-ocular-implants-global-forecasts-to-2017.html .
The hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to factors such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Competitive Situations & Trends
4 Product Launches & Approvals
5 Partnerships, Agreements, and Collaborations
6 Acquisitions, Mergers, and Joint Ventures
7 Expansions
Additionally, the increasing need for drug administration due to the rising prevalence of chronic diseases, patient compliance, and safety are all factors contributing to the growth of the market for hospitals.
Contact Information:
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Mr. Hrishikesh
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results